SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Emery P. The optimal management of early rheumatoid disease: the key to preventing disability. Br J Rheumatol 1994; 33: 7658.
  • 2
    Van der Heijde D, Dankert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 9417.
  • 3
    Scott D, Houssein D, Laasonen L. Proposed modification to Larsen's scoring methods for hand and wrist radiographs. Br J Rheumatol 1995; 34: 56.
  • 4
    Sharp J. Scoring radiographic abnormalities in rheumatoid arthritis. Radiol Clin North Am 1996; 34: 23341.
  • 5
    Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol 1995; 22: 19745.
  • 6
    US Department of Health and Human Services, Food and Drug Administration. Guidance for industry: clinical development programs for drugs, devices and biological products for the treatment of rheumatoid arthritis (RA). Accessed May 16, 2002. URL: http://www.fda.gov/cder/guidance/index.htm.
  • 7
    McGonagle D, Conaghan PG, O'Connor P, Gibbon W, Green M, Wakefield R, et al. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum 1999; 42: 170611.
  • 8
    Jevtic V, Watt I, Rozman B, Presetnik M, Logar D, Praprotnik S, et al. Prognostic value of contrast enhanced Gd-DTPA MRI for development of bone erosive changes in rheumatoid arthritis. Br J Rheumatol 1996; 35 Suppl 3: 2630.
  • 9
    Gaffney K, Cookson J, Blades S, Coumbe A, Blake D. Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging. Ann Rheum Dis 1998; 57: 1527.
  • 10
    Østergaard M, Stoltenberg M, Gideon P, Sorensen K, Henriksen O, Lorenzen I. Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone: quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol 1996; 23: 115161.
  • 11
    McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 1998; 57: 3506.
  • 12
    McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 1999; 58: 15663.
  • 13
    McQueen FM, Benton N, Crabbe J, Robinson E, Yeoman S, McLean L, et al. What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis 2001; 60: 85968.
  • 14
    Edmonds JP, Lassere MN. Imaging damage: scoring versus measuring. J Rheumatol 2001; 28: 174951.
  • 15
    Østergaard M, Klarlund M, Lassere M, Conaghan P, Peterfy C, McQueen F, et al. Interreader agreement in the assessment of magnetic resonance images of rheumatoid arthritis wrist and finger joints—an international multicenter study. J Rheumatol 2001; 28: 114350.
  • 16
    Klarlund M, Østergaard M, Jensen KE, Madsen JL, Skjodt H, Lorenzen I, the TIRA Group. Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. Ann Rheum Dis 2000; 59: 5218.
  • 17
    Nakahara N, Uetani M, Hayashi K, Kawahara Y, Matsumoto T, Oda J. Gadolinium-enhanced MR imaging of the wrist in rheumatoid arthritis: value of fat suppression pulse sequences. Skeletal Radiol 1996; 25: 63947.
  • 18
    Takeuchi K, Inoue H, Yokoyama Y, Senda M, Ota Y, Abe N, et al. Evaluation of rheumatoid arthritis using a scoring system devised from magnetic resonance imaging of rheumatoid knees. Acta Med Okayama 1998; 52: 21124.
  • 19
    Lassere M. Pooled meta-analysis of radiographic progression: comparison of Sharp and Larsen methods. J Rheumatol 2000; 27: 26975.
  • 20
    Spiegel TM, Spiegel JS, Paulus HE. The joint alignment and motion scale: a simple measure of joint deformity in patients with rheumatoid arthritis. J Rheumatol 1987; 14: 88792.
  • 21
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993; 36: 72940.
  • 22
    Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 23
    Zlonis M. The mystique of the erythrocyte sedimentation rate: a reappraisal of one of the oldest laboratory tests still in use. Clin Lab Med 1993; 13: 787800.
  • 24
    Pepys MB. C-reactive protein: fifty years on. Lancet 1981; 1: 6537.
  • 25
    Huang J, Stewart N, Crabbe J, Robinson E, McLean L, Yeoman S, et al. A 1-year follow-up study of dynamic magnetic resonance imaging in early rheumatoid arthritis reveals synovitis to be increased in shared epitope-positive patients and predictive of erosions at 1 year. Rheumatology (Oxford) 2000; 39: 40716.
  • 26
    Prendergast N, Rauschning W. Normal anatomy of the hand and wrist. Magn Reson Imaging Clin N Am 1995; 3: 197212.
  • 27
    Conaghan P, Edmonds J, Emery P, Genant H, Gibbon W, Klarlund M, et al. Magnetic resonance imaging in rheumatoid arthritis: summary of OMERACT activities, current status, and plans. J Rheumatol 2001; 28: 115862.
  • 28
    Edmonds J, Saudan A, Lassere M, Scott D. Introduction to reading radiographs by the Scott modification of the Larsen method. J Rheumatol 1999; 26: 7402.
  • 29
    Shrout P, Fleiss J. Intra-class correlations: using in assessing rater reliability. Psychol Bull 1979; 86: 4208.
  • 30
    Lassere M, Boers M, van der Heijde D, Boonen A, Edmonds J, Saudan A, et al. Smallest detectable difference in radiological progression. J Rheumatol 1999; 26: 7319.
  • 31
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 30710.
  • 32
    Prevoo MLL, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM. Modified disease activity scores that include twenty-eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 448.
  • 33
    Lassere M, van der Heijde D, Johnson K, Bruynesteyn K, Molenaar E, Boonen A. Robustness and generalisability of smallest detectable difference in radiological progression. J Rheumatol 2001; 28: 9113.
  • 34
    Østergaard M, Stoltenberg M, Henriksen O, Lorenzen I. The accuracy of MRI determined synovial membrane and joint effusion volumes in arthritis. Scand J Rheumatol 1995; 24: 30511.
  • 35
    Boers M, Brooks P, Strand V, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998; 25: 1989.
  • 36
    Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977; 18: 48191.
  • 37
    Scott D, Laasonen L, Priolo F, Houssein D, Bacarini L, Cerase A, et al. The radiological assessment of rheumatoid arthritis. Clin Exp Rheumatol 1997; 15 Suppl 17: S53S61.
  • 38
    Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999; 26: 7435.
  • 39
    Van der Heijde DM. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Baillieres Clin Rheumatol 1996; 10: 43553.
  • 40
    Higgs JB, Smith D, Des Rosier KF, Charlesworth RW Jr. Quantitative measurement of erosion growth and joint space loss in rheumatoid arthritis hand radiographs. J Rheumatol 1996; 23: 26572.
  • 41
    Angwin J, Heald G, Lloyd A, Howland K, Davy M, James MF. Reliability and sensitivity of joint space measurements in hand radiographs using computerized image analysis. J Rheumatol 2001; 28: 182536.
  • 42
    Sharp JT, Gardner JC, Bennett EM. Computer-based methods for measuring joint space and estimating erosion volume in the finger and wrist joints of patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 137886.
  • 43
    Lassere M, McQueen F, Østergaard M, Conaghan P, Schnier R, Peterfy C, et al. Performance of an MRI score of rheumatoid arthritis activity and damage. Arthritis Rheum 2001; 44 Suppl 9: S222.
  • 44
    Lassere M, Bird P. Measurement of RA disease activity and damage using MRI. Truth and discrimination: does MRI make the grade? J Rheumatol 2001; 28: 11517.
  • 45
    Lassere M, van der Heijde D, Johnson K, Boers M, Edmonds J. The reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for the smallest detectable difference (SDD), the minimum clinical important difference (MCID) and the analysis of treatment effects in randomized controlled trials. J Rheumatol 2001; 28: 892903.
  • 46
    Østergaard M, Gideon P, Stoltenberg M, Henriksen O, Lorenzen I. Volumes of synovial membrane and joint effusion determined by MR imaging. Markers of severity and/or activity in rheumatoid arthritis? Ugeskr Laeger 1997; 159: 395661. In Danish.
  • 47
    Østergaard M, Stoltenberg M, Gideon P. Effect of intraarticular osmic acid on synovial membrane volume and inflammation determined by magnetic resonance imaging. Scand J Rheumatol 1995; 24: 512.
  • 48
    Østergaard M. Different approaches to synovial membrane volume determination by magnetic resonance imaging: manual versus automated segmentation. Br J Rheumatol 1997; 36: 116677.
  • 49
    Østergaard M, Hansen M, Stoltenberg M, Gideon P, Klarlund M, Jensen KE, et al. Magnetic resonance imaging–determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 91829.
  • 50
    Klarlund M, Østergaard M, Lorenzen I. Finger joint synovitis in rheumatoid arthritis: quantitative assessment by magnetic resonance imaging. Rheumatology (Oxford) 1999; 38: 6672.
  • 51
    Cimmino M, Bountis C, Silvestri E, Garlaschi G, Accardo S. An appraisal of magnetic resonance imaging of the wrist in rheumatoid arthritis. Semin Arthritis Rheum 2000; 30: 18095.
  • 52
    Sugimoto H, Takeda A, Masuyama J, Furuse M. Early stage rheumatoid arthritis: diagnostic accuracy of MR imaging. Radiology 1996; 198: 18592.
  • 53
    Klarlund M, Østergaard M, Rostrup E, Skjødt H, Lorenzen I. Dynamic magnetic resonance imaging of the metacarpophalangeal joints in rheumatoid arthritis, early unclassified polyarthritis, and healthy controls. Scand J Rheumatol 2000; 29: 10815.
  • 54
    Østergaard M, Stoltenberg M, Løvgreen-Nielsen P, Volck B, Jensen CH, Lorenzen I. Magnetic resonance imaging–determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis: comparison with the macroscopic and microscopic appearance of the synovium. Arthritis Rheum 1997; 40: 185667.
  • 55
    Ostendorf B, Peters R, Dann P, Becker A, Scherer A, Wedekind F, et al. Magnetic resonance imaging and miniarthroscopy of metacarpophalangeal joints: sensitive detection of morphologic changes in rheumatoid arthritis. Arthritis Rheum 2001; 44: 2492502.
  • 56
    Feigenbaum H. Evolution of echocardiography. Circulation 1996; 93: 13217.
  • 57
    Faulkner KG. Update on bone density measurement. Rheum Dis Clin North Am 2001; 27: 8199.
  • 58
    Sambrook PN, Naganathan V. How do we manage specific types of osteoporosis? Baillieres Clin Rheumatol 1997; 11: 597612.